ACP Updates Living Guideline on Pharmacologic Treatment of Osteoporosis
TUESDAY, Jan. 3, 2023 (HealthDay News) — In a living clinical guideline issued by the American College of Physicians (ACP) and published online Jan. 3 in the Annals of Internal Medicine, updated recommendations are presented for the pharmacologic tre…
Learn MoreOccurrence of Cardiovascular Events, Death Compared Between Thiazides
TUESDAY, Jan. 3, 2023 (HealthDay News) — For patients receiving thiazide diuretics, the occurrence of major cardiovascular outcome events or non-cancer-related deaths is no lower for those receiving chlorthalidone versus those receiving hydrochloroth…
Learn MoreProgression-Free Survival Increased With Zanubrutinib in Leukemia
TUESDAY, Jan. 3, 2023 (HealthDay News) — Progression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), according t…
Learn MoreNew COVID Pill May Be Improvement Over Paxlovid, Chinese Trial Suggests
FRIDAY, Dec. 30, 2022 (HealthDay News) — COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease. The treatment, called VV116, worked as well as Paxlovid in people who were at high risk of severe disease i…
Learn MoreCongressional Report Slams FDA, Drugmaker Over Approval of Alzheimer Drug Aduhelm
THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration approval process for the controversial Alzheimer drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to slow t…
Learn MoreMolnupiravir Does Not Reduce COVID-19-Related Hospitalization, Death
THURSDAY, Dec. 29, 2022 (HealthDay News) — For high-risk vaccinated adults, molnupiravir plus usual care does not reduce the frequency of COVID-19-associated hospitalizations or deaths, according to a study published online Dec. 22 in The Lancet.Chri…
Learn More5α-Reductase Inhibitors Linked to Depression, but Not Dementia
THURSDAY, Dec. 29, 2022 (HealthDay News) — 5α-reductase inhibitors (5-ARIs) are associated with an increased risk for depression but seem not to be associated with dementia, according to a study published online Dec. 22 in JAMA Network Open.Miguel Ga…
Learn MoreAvoiding Opioids, Many Patients in Pain Get Gabapentin Instead. Does It Work?
FRIDAY, Dec. 22, 2022 (HealthDay News) — As doctors have tried to steer their chronic pain patients away from highly addictive opioids, many have turned to two antiseizure drugs, but a new review finds they are only “modestly effective” at treating p…
Learn MoreWeekly Dupilumab Beneficial in Eosinophilic Esophagitis
THURSDAY, Dec. 22, 2022 (HealthDay News) — Subcutaneous dupilumab administered weekly is associated with improved histologic outcomes and alleviation of symptoms among patients with eosinophilic esophagitis, according to a study published in the Dec….
Learn MoreLos médicos y sus familias son menos propensos a seguir las directrices médicas que los demás
MARTES, 20 de diciembre de 2022 (HealthDay News) — Los médicos son famosos por criticar a los pacientes que no toman los fármacos según las indicaciones.Pero los médicos y sus familias son menos propensos que todos los demás a cumplir las directrices…
Learn More